QbTest for ADHD assessment and medication management: a mixed-methods systematic review of impact on clinical outcomes and patient, carer and clinician experiences.

ABSTRACT:

Objectives

To explore patient, carer and clinician experiences of the QbTest and its impact on patient outcomes for attention deficit hyperactivity disorder (ADHD) diagnosis and medication management.

Design

Mixed-methods systematic review.

Data sources

MEDLINE, EMBASE, PsycINFO, CINAHL, ClinicalTrials.gov and WHO ICTRP (from inception to September 2024).

Study selection

Primary studies, of any design, that evaluated any version of the QbTest (QbMini <5 years, QbTest 6-12 or 12-60 years, QbCheck for remote assessment via webcam or QbMT smartphone version), for ADHD diagnosis and/or medication management and provided data on any of the following outcomes, were eligible: time to assessment/diagnostic decision, use of services, impact on clinical decision-making,

SUBMITTER: Tomlinson E 

PROVIDER: S-EPMC12007030 | biostudies-literature | 2025 Apr

REPOSITORIES: biostudies-literature